Product
GLP-1
3 clinical trials
4 indications
Indication
Cystic FibrosisIndication
Pancreatic InsufficiencyIndication
Increntin EffectIndication
Insulin SecretionClinical trial
Determination of Beta-cell Responsiveness to the Incretin Hormones GLP-1 and GIP in Cystic FibrosisStatus: Recruiting, Estimated PCD: 2025-12-01
Clinical trial
The Effect of Glucose-dependent Insulinotropic Polypeptide (GIP), Glucagon-like Peptide-1 (GLP-1) and Glucagon-like Peptide-2 (GLP-2) in Individuals With Genetically Altered Receptor FunctionStatus: Recruiting, Estimated PCD: 2027-12-01
Clinical trial
Incretin Action in Physiology and DiabetesStatus: Completed, Estimated PCD: 2021-04-16